What You Should Know:
– DrFirst, a provider of e-prescribing, price transparency, and medication management solutions, announced today the closing of a $50 million equity investment from Sixth Street Growth, a leading global investment firm. Following Sixth Street’s previous $35 million investment and another $50 million from Goldman Sachs Growth, both in 2020, DrFirst’s investment total over the past year is now $135 million.
– The company’s solution is used by nearly 300,000 healthcare professionals, including more than 100,000 prescribers, nearly half of the EHRs in the U.S., and more than 1,400 hospitals in the U.S. and Canada.
– The scale of this funding will help physicians provide better, more informed care, which ultimately accrues to the benefit of patients and all healthcare stakeholders
– DrFirst’s sustained business growth, long-standing work with leading health systems, expanding customer base, and proven leadership in the digital health solutions market underscore the investments. The scale of this funding will help physicians provide better, more informed care, which ultimately accrues to the benefit of patients and all healthcare stakeholders.
